US stock futures Down feb 10 2012 , why us stock down feb 10 2012 : US equity markets looked set to open lower Friday morning after more conditions were demanded for Greece before it got more financial aid. In pre-market trading, the Dow Jones Industrial Average fell 0.4% to 12,790, the S&P 500 slipped 0.5% to 1,341.30 and the NASDAQ was down 0.44% to 2,549.75.
Thursday US markets ended in the green with the Dow up 0.05%, the S&P 500 was up 0.15% and the NASDAQ ended the session up 0.39%.
NYSE Euronext (NYSE:NYX) narrowly beat analyst forecasts but profits fell in the fourth quarter, related to costs on the abandoned merger with Deutsche Boerse. Net income fell to $110 million, or 43 cents a share, from $135 million, or 51 cents a share, a year earlier.
Excluding some items, earnings were 50 cents per share, beating the 48-cent average estimate of 16 analysts surveyed by Bloomberg. NYSE reported $46 million in one-time "merger expenses and exit costs" in the quarter, of which $38 million related to the failed Deutsche Boerse deal.
LinkedIn Corp. (NASDAQ:LNKD) late Thursday reported adjusted fourth-quarter earnings of 12 cents a share late the prior day, against expectations for 7 cents a share.
Activision Blizzard's (NASDAQ:ATVI) quarterly sales beat Wall Street expectations on Thursday as the video game publisher lost fewer "World of Warcraft" subscribers than it did a quarter ago.
Fourth-quarter sales for the three months ended December 30 fell 6% to $2.4 billion. Analysts were expecting sales of $2.2 billion, according to Thomson Reuters.
Adjusted for the deferral of revenue from digital content, Activision posted a profit of $725 million, or 62 cents per share, which beat Wall Street estimates of 56 cents a share.
Procter & Gamble (NYSE:PG) may seek to terminate a proposed $1.5 billion sale of its Pringles snack business to Diamond Foods (NASDAQ:DMND) following an accounting probe at Diamond that saw the suspension of key management.
For the latest updates on the stock market, visit Stock Market Today
No comments:
Post a Comment